April 28, 2013 article Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib Annals of Hematology DOI: 10.1007/s00277-013-1769-2 OpenAlex Authors 0 Author list not loaded yet. Cited by 1 stored of 51 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Chronisch myeloische Leukämie 2023 DMW - Deutsche Medizinische Wochenschrift article Medicine Chronic Myeloid Leukemia Treatments 0 citations 1 result References 0